GE Medical Systems had finalized its acquisition of Mecon, a developer of data mining and Internet-based benchmarking products for the healthcare field. Mecon, of San Ramon, CA, will now operate as a wholly owned subsidiary of GE. As a result of the
GE Medical Systems had finalized its acquisition of Mecon, a developer of data mining and Internet-based benchmarking products for the healthcare field. Mecon, of San Ramon, CA, will now operate as a wholly owned subsidiary of GE. As a result of the merger, Mecon shareholders will receive 0.081 shares of GE stock for each share of Mecon stock held at the close of the merger, plus cash for any fractional shares. David Allinson, Mecons CFO, will assume the role of president and CEO, while Vasu Devan, president and CEO of Mecon since the company was founded, will continue in an advisory capacity.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.